Devereux, GrahamSteele, SandraGriffiths, KairenDevlin, EdwardFraser-Pitt, DouglasCotton, SeonaidhNorrie, JohnChrystyn, HenryO'Neil, Deborah2016-05-092016-05-092016-08Devereux, G, Steele, S, Griffiths, K, Devlin, E, Fraser-Pitt, D, Cotton, S, Norrie, J, Chrystyn, H & O'Neil, D 2016, 'An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis', Clinical Drug Investigation, vol. 36, no. 8, pp. 605-612. https://doi.org/10.1007/s40261-016-0405-z1173-2563http://hdl.handle.net/2164/5972Acknowledgments Trial Steering Committee: Dr Steve Cunningham (chair), Dr Stephen Bourke, Dr Gordon MacGregor. We are grateful to all the participants who took part in the study. We are also grateful to the support from the Clinical Trials Pharmacy at Aberdeen Royal Infirmary. Role of the funding source This study was funded by Health Sciences Scotland (West Medical Building, University Avenue, Glasgow G12 8QQ. UK) and the Cystic Fibrosis Trust (One Aldgate, London. EC3N 1RE. UK). The funders did not contribute to study design, data collection, analysis, this report or the decision to publish.8540032engR MedicineRAn Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic FibrosisJournal article10.1007/s40261-016-0405-z368